| Authors: |
Francies FZ; SAMRC/UP Precision Prevention & Novel Drug Targets for HIV-Associated Cancers (PPNDTHAC) Extramural Unit, Pan African Cancer Research Institute (PACRI), University of Pretoria, Hatfield 0028, South Africa., Bassa S; Department of Radiation Oncology, Steve Biko Academic Hospital (SBAH), Faculty of Health Sciences, University of Pretoria, Hatfield 0028, South Africa., Chatziioannou A; SAMRC/UP Precision Prevention & Novel Drug Targets for HIV-Associated Cancers (PPNDTHAC) Extramural Unit, Pan African Cancer Research Institute (PACRI), University of Pretoria, Hatfield 0028, South Africa.; Center of Systems Biology, Biomedical Research Foundation Academy of Athens, 4 Soranou Ephessiou str, 115 27 Athens, Greece., Kaufmann AM; SAMRC/UP Precision Prevention & Novel Drug Targets for HIV-Associated Cancers (PPNDTHAC) Extramural Unit, Pan African Cancer Research Institute (PACRI), University of Pretoria, Hatfield 0028, South Africa.; Clinic for Gynaecology, Laboratory for Gynaecologic Tumor Immunology, Institute of Health, Charité-Universitätsmedizin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Augustenburgerplatz 1, 13353 Berlin, Germany., Dlamini Z; SAMRC/UP Precision Prevention & Novel Drug Targets for HIV-Associated Cancers (PPNDTHAC) Extramural Unit, Pan African Cancer Research Institute (PACRI), University of Pretoria, Hatfield 0028, South Africa. |
